These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30327620)

  • 21. Understanding and treating patients with alcoholic cirrhosis: an update.
    Addolorato G; Russell M; Albano E; Haber PS; Wands JR; Leggio L
    Alcohol Clin Exp Res; 2009 Jul; 33(7):1136-44. PubMed ID: 19389182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [GABAB receptor as therapeutic target for drug addiction: from baclofen to positive allosteric modulators].
    Agabio R; Colombo G
    Psychiatr Pol; 2015; 49(2):215-23. PubMed ID: 26093587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alcohol treatment discussions and clinical outcomes among patients with alcohol-related cirrhosis.
    Alexandre W; Muhammad H; Agbalajobi O; Zhang G; Gmelin T; Adejumo A; Noll A; Jonassaint NL; DiMartini A; Bataller R; Rogal SS
    BMC Gastroenterol; 2023 Feb; 23(1):29. PubMed ID: 36732709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized open-label trial of baclofen for relapse prevention in alcohol dependence.
    Gupta M; Verma P; Rastogi R; Arora S; Elwadhi D
    Am J Drug Alcohol Abuse; 2017 May; 43(3):324-331. PubMed ID: 27808555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of alcohol misuse in patients with liver diseases.
    Peng JL; Patel MP; McGee B; Liang T; Chandler K; Tayarachakul S; O'Connor S; Liangpunsakul S
    J Investig Med; 2017 Mar; 65(3):673-680. PubMed ID: 27940551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the GABA(B) receptor system in alcoholism and stress: focus on clinical studies and treatment perspectives.
    Addolorato G; Leggio L; Cardone S; Ferrulli A; Gasbarrini G
    Alcohol; 2009 Nov; 43(7):559-63. PubMed ID: 19913201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Review of the Potential Mechanisms of Action of Baclofen in Alcohol Use Disorder.
    de Beaurepaire R
    Front Psychiatry; 2018; 9():506. PubMed ID: 30459646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baclofen and naltrexone effects on alcohol self-administration: Comparison of treatment initiated during abstinence or ongoing alcohol access in baboons.
    Holtyn AF; Kaminski BJ; Weerts EM
    Drug Alcohol Depend; 2017 Oct; 179():47-54. PubMed ID: 28753481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Predictors of Response to Baclofen in the Treatment of Alcohol use Disorder: Results from the BacALD Trial.
    Rombouts SA; Baillie A; Haber PS; Morley KC
    Alcohol Alcohol; 2019 May; 54(3):272-278. PubMed ID: 30977770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychosocial and Pharmacological Therapies to Reduce Alcohol Consumption in Severe Alcohol-Related Hepatitis Patients: A Case Report.
    Awan H; Vergis N
    Cureus; 2023 Apr; 15(4):e37443. PubMed ID: 37182058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender Disparities in Alcohol Use Disorder Treatment Among Privately Insured Patients with Alcohol-Associated Cirrhosis.
    Mellinger JL; Fernandez A; Shedden K; Winder GS; Fontana RJ; Volk ML; Blow FC; Lok ASF
    Alcohol Clin Exp Res; 2019 Feb; 43(2):334-341. PubMed ID: 30667521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alcohol addiction - the safety of available approved treatment options.
    Antonelli M; Ferrulli A; Sestito L; Vassallo GA; Tarli C; Mosoni C; Rando MM; Mirijello A; Gasbarrini A; Addolorato G
    Expert Opin Drug Saf; 2018 Feb; 17(2):169-177. PubMed ID: 29120249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. State-of-the-art behavioral and pharmacological treatments for alcohol use disorder.
    Ray LA; Bujarski S; Grodin E; Hartwell E; Green R; Venegas A; Lim AC; Gillis A; Miotto K
    Am J Drug Alcohol Abuse; 2019; 45(2):124-140. PubMed ID: 30373394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of Alcohol Relapse Among Liver Transplant Candidates With Less Than 6 Months of Abstinence Using the High-Risk Alcoholism Relapse Score.
    Lombardo-Quezada J; Colmenero J; López-Pelayo H; Gavotti C; Lopez A; Crespo G; Lopez E; Gual A; Lligoña A; Navasa M
    Liver Transpl; 2019 Aug; 25(8):1142-1154. PubMed ID: 30920118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver transplantation and alcoholic liver disease: History, controversies, and considerations.
    Marroni CA; Fleck AM; Fernandes SA; Galant LH; Mucenic M; de Mattos Meine MH; Mariante-Neto G; Brandão ABM
    World J Gastroenterol; 2018 Jul; 24(26):2785-2805. PubMed ID: 30018475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing alcohol versus baclofen withdrawal syndrome in patients treated with baclofen for alcohol use disorder.
    Rolland B; Jaillette E; Carton L; Bence C; Deheul S; Saulnier F; Bordet R; Cottencin O
    J Clin Psychopharmacol; 2014 Feb; 34(1):153-6. PubMed ID: 24346755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness and safety of baclofen in the treatment of alcohol dependent patients.
    Leggio L; Garbutt JC; Addolorato G
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):33-44. PubMed ID: 20201813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose baclofen for the treatment of alcohol dependence (BACLAD study): a randomized, placebo-controlled trial.
    Müller CA; Geisel O; Pelz P; Higl V; Krüger J; Stickel A; Beck A; Wernecke KD; Hellweg R; Heinz A
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1167-77. PubMed ID: 26048580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence.
    Addolorato G; Caputo F; Capristo E; Colombo G; Gessa GL; Gasbarrini G
    Alcohol Clin Exp Res; 2000 Jan; 24(1):67-71. PubMed ID: 10656195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety Challenges of Using High Dose Baclofen for Alcohol Use Disorder: A Focused Review.
    Rolland B; Simon N; Franchitto N
    Front Psychiatry; 2018; 9():367. PubMed ID: 30186187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.